Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
---|
05/14/2008 | CN101180294A Pyran/dioxan derivatives and use thereof in liquid crystal media |
05/14/2008 | CN101180293A Naphthalamide derivatives having antiproliferative activity |
05/14/2008 | CN101180285A Formyltetrahydropyrans, method for the production thereof and use thereof in the production of liquid crystal compounds |
05/14/2008 | CN101177424A High-purity silybin meglumine, preparation method as well as application in preparing medicine treating hepatitis and liver hurt thereof |
05/14/2008 | CN100387706C Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
05/13/2008 | US7371745 Bis-transition-metal-chelate probes |
05/08/2008 | WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors |
05/08/2008 | WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
05/08/2008 | US20080108837 Separating a terpene trilactone from Ginkgo biloba plant material; column chromatography; large-scale isolation of ginkgolides as phytopharmaceuticals |
05/08/2008 | US20080108610 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae) |
05/08/2008 | US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics |
05/08/2008 | US20080107821 Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound |
05/08/2008 | US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same |
05/08/2008 | CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors |
05/07/2008 | EP1917323A1 Novel materials for organic electroluminescent devices |
05/07/2008 | EP1917260A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
05/07/2008 | CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
05/07/2008 | CN101175740A Dihydrobenzofuran derivatives and uses thereof |
05/07/2008 | CN101172971A Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof |
05/06/2008 | US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl. |
05/06/2008 | US7368582 Potassium channel blocker; sulfonylation of the corresponding 4-aminochromene; cardiac arrhythmias; marked atrial-selective action profile; proliferative diseases, chronic inflammatory diseases, autoimmune diseases |
05/06/2008 | US7368579 E.g., 2-bromo- or 2-chloro-1-(2-methyl-2-oxiranylmethyl)-4-nitroimidazole; intermediates for antitubercular agents |
05/06/2008 | US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
05/06/2008 | US7368434 Alcoholism therapy |
05/06/2008 | US7368101 Process for the preparation of iopamidol and the new intermediates therein |
05/06/2008 | CA2244979C Proton conductor in liquid form |
05/02/2008 | WO2008049923A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
05/02/2008 | WO2008049875A1 Novel substituted piperidyl-propane-thiols |
05/02/2008 | CA2667550A1 Crystalline form of 4-(.beta.-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
05/02/2008 | CA2667548A1 Substituted piperidyl-propane-thiols |
05/01/2008 | US20080103320 Total Synthesis of Myriaporones |
05/01/2008 | US20080103194 Anti-first-pass effect compounds |
04/30/2008 | EP1916249A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents |
04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
04/23/2008 | EP1914229A1 Novel cercosporamide derivative |
04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
04/23/2008 | EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
04/23/2008 | CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
04/17/2008 | WO2008045945A1 Benzindole derivatives and method of treating hiv/aids |
04/17/2008 | WO2008044217A2 2-aminocarbonyl-pyridine derivatives |
04/17/2008 | WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
04/17/2008 | WO2008008887A3 Gpr119 agonists for treating metabolic disorders |
04/17/2008 | US20080090901 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-chagas chemoprophylactic and therapeutical activities |
04/17/2008 | CA2664579A1 2-aminocarbonyl-pyridine derivatives |
04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
04/16/2008 | EP1909791A1 G-protein coupled receptor agonists |
04/16/2008 | EP1909572A2 Potassium channel inhibitors |
04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
04/16/2008 | CN100381437C Compounds, compositions and methods |
04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
04/15/2008 | US7358377 Schweinfurthin analogues |
04/15/2008 | CA2343310C Polymerizable polyalkoxylated naphthopyrans |
04/10/2008 | WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
04/10/2008 | WO2008040528A2 Process for preparing nebivolol |
04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
04/10/2008 | WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
04/10/2008 | US20080086010 reacting 4-chloro-3-methyl-5-(3-oxo-thieno(2,3-d) isothiazole-1,1-dioxide with 5-methyl-7-metal, metal halide or metal complex-methyl-,13-benzodioxole |
04/10/2008 | US20080085929 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same |
04/10/2008 | CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
04/10/2008 | CA2663339A1 Process for preparing nebivolol |
04/09/2008 | EP1907382A1 Nitrocatechol derivatives as comt inhibitors |
04/09/2008 | EP1907380A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
04/09/2008 | EP1907361A1 Amide derivatives as kinase inhibitors |
04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
04/09/2008 | CN101160305A Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
04/09/2008 | CN101157689A Complex salt of Silybin and oxymatrine or matrine and uses thereof |
04/08/2008 | US7355054 Indole derivatives |
04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
04/03/2008 | WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
04/02/2008 | EP1904486A2 Processes for the synthesis of 3-isobutylglutaric acid |
04/02/2008 | EP1904485A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
04/02/2008 | EP1729759A4 Salvinorin derivatives and uses thereof |
04/02/2008 | CN101153038A A process for the preparation of phenyltetrazole compounds |
04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
03/27/2008 | WO2008036216A1 Piperidine derivatives as renin inhibitors |
03/27/2008 | WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
03/27/2008 | WO2008011560A3 Benzothiophene inhibitors of rho kinase |
03/27/2008 | WO2008009405A3 Novel pyridazine derivatives |
03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
03/27/2008 | WO2007103370A3 Quinazoline derivatives as phosphodiesterase 10 inhibitors |
03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
03/27/2008 | CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
03/26/2008 | CN101148444A Flavone derivative, preparation method and application |
03/26/2008 | CN101148442A Histone deacetylase inhibitor and its preparation method and use |
03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |